Latest news

• Global pledge to immunise 300 million children

  Commitment made at GAVI Pledging Conference follows criticism of high vaccine prices. ... The medical charity Médecins Sans Frontières (MSF) used the build-up to the conference to highlight the high prices of some new vaccines, including shots made by

• Pfizer's Prevenar 13 price cut slammed by MSF

  Pfizer has reduced the price of its pneumococcal vaccine Prevenar 13 for an immunisation programme targeting low-income countries, but has been criticised for not going far enough. ... The US pharma giant said it would cut the price of Prevenar 13

• GSK and Pfizer extend vaccine access programme

  Elder commented that another unnamed pharma company was looking to offer a vaccine at $2 a dose, although it would be several years before this was available. ... MSF is unable to systematically access the PCV vaccine at the GAVI negotiated prices,

• GSK partners AIDS charity

  IAVI will contribute technical expertise and funding, while GSK has pledged to make the vaccine available at affordable prices to developing countries if it is successful. ... World leaders at the forthcoming G8 summit are expected to extend support for

• Flu urges vaccine rush

  Vaccine manufacturers also continue to face liability problems and low payments from health insurers. ... The jewel however is a papillomavirus vaccine, Gardasil, for the prevention of cervical cancer.